nasdaq
(6)
The $7 Billion Cable Empire Nobody Wanted, Now Trading Under Its Own Name
Comcast handed its cable networks a name, a ticker and a mandate to survive the streaming era. What Versant does with CNBC, MS NOW and $7 billion in revenue is now its own problem to solve.
The Stock Exchange That Became a Software Company
Nasdaq still rings the bell. But the business behind the blue-lit tower increasingly sells the machinery, data and risk controls that keep markets running long after the ceremony ends.
Swarmer
Swarmer builds combat-proven, hardware-agnostic autonomy software that lets a single operator command hundreds of drones - across air, sea and ground - as one coordinated swarm. Born out of the war in Ukraine and founded in 2023, its STYX, MINAS and TRIDENT products translate human objectives into autonomous action while keeping people in control of life-or-death decisions. The company's software has supported more than 100,000 real-world combat missions, raised a record $15M Series A, and went public on the Nasdaq in 2026 under the ticker SWMR.
Cadence Design Systems
Cadence Design Systems is a San Jose-based computational software company that builds the electronic design automation (EDA) tools, hardware systems, and semiconductor IP used to design chips, printed circuit boards, and full electromechanical systems. Under its Intelligent System Design strategy, Cadence software sits behind a large share of the world's advanced silicon - powering everything from smartphones and data-center accelerators to cars, aircraft, and, increasingly, AI-driven design automation and drug discovery.
FibroGen, Inc.
FibroGen, Inc. is a San Francisco biopharmaceutical company that spent three decades building first-in-class medicines around hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology. Its best-known drug, roxadustat, is an oral treatment for anemia approved in China, Japan and Europe. After selling its China business to AstraZeneca in 2025 and paying down debt, the company rebranded as Kyntra Bio (Nasdaq: KYNB) in January 2026 to concentrate on oncology and rare disease, led by FG-3246, a first-in-class CD46-targeting antibody-drug conjugate for metastatic prostate cancer.
Monday CRM
Monday.com is a publicly traded Israeli SaaS company (NASDAQ: MNDY) that builds a Work OS platform used by 245,000+ organizations globally. Its flagship products include Monday CRM, Monday Dev, and Monday WorkOS — a suite of customizable tools for sales, project management, and team collaboration. Founded in 2012, the company has grown from an internal Wix.com tool to a $1B+ ARR business with AI-powered agents, workflow automation, and deep integrations with 200+ enterprise tools.